This episode currently has no reviews.
Submit ReviewMel Engle, executive and cancer survivor, has spent more than 30 years in and around the intersection of healthcare and technology. He's now the CEO of Predictive Oncology using AI and patient data to develop personalized cancer treatments. Mel discusses how research from Carnegie Mellon is being commercialized to accelerate the future of healthcare.Listen and learn...
References in this episode:
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review